The U.S. previously recommended more childhood vaccines than any peer nation, according to the HHS, which pointed out that ...

Shortly after scoring a historic FDA nod for its Wegovy pill, Novo Nordisk is off to the races with the oral obesity med’s ...

Daiichi Sankyo plans to splash out some 300 billion yen ($1.9 billion) on Enhertu manufacturing facilities across the globe, ...

After shepherding the company through its first approval and the successful launch of blockbuster autoimmune drug Vyvgart, ...

A recent survey shows that healthcare professionals have varied feelings on the direct-to-patient (DTP) drug sale platforms ...

Initiatives from former President Joe Biden and current President Donald Trump have been effective in reducing the prices of ...

Bausch + Lomb has partnered with the glaucoma community once again, launching its fifth annual fundraising challenge and ...

A positive top-line readout from a phase 3 trial has emboldened Incyte to seek the FDA’s blessing for the company’s Monjuvi ...

Welcome to Fierce Pharma's regulatory tracker for the first half of 2026. | In this tracker, Fierce Pharma is recording the ...

Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...

The emergence of next-generation KRAS G12C inhibitors has led Verastem Oncology to change course. | The emergence of ...

Vanda also sells sleep disorder drug Hetlioz, which reached the market in 2014, and relapsing multiple sclerosis treatment ...